Research Article
Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial
Table 1
General characteristics of participants.
| Variable | SJDBT group
| Placebo group
| p value | Mean ± SD | Mean ± SD |
| Age | | | 0.718 | Gender | | | | Male | 1 (6.2%) | 1 (6.2%) | 1.000 | Female | 15 (93.8%) | 15 (93.8%) | Anthropometric measurements | | | | Height, cm | | | 0.178 | Weight, kg | | | 0.831 | BMI | | | 0.424 | FAACT scale | | | 0.942 | FAACT ACS scale | | | 0.711 | Anorexia VAS | | | 0.937 | Systolic blood pressure (SBP), mmHg | | | 0.275 | Diastolic blood pressure (DBP), mmHg | | | 0.168 | Pulse, bpm | | | 0.929 | ACTH | | | 0.771 | Cortisol | | | 0.995 | Ghrelin | | | 0.528 | Interleukin 6 | | | 0.883 | ESR | | | 0.717 | CRP | | | 0.983 | Cancer type | | | | Breast cancer | 3 (18.8%) | 4 (25.0%) | 0.267 | Cervical cancer | 2 (12.5%) | 0 (0.0%) | Colon cancer | 1 (6.2%) | 1 (6.2%) | Gastric cancer | 3 (18.8%) | 0 (0.0%) | Lung cancer | 1 (6.2%) | 3 (18.8%) | Thyroid cancer | 6 (37.5%) | 8 (50.0%) | Anticancer therapy | | | | Chemo- and radiotherapy | 3 (18.8%) | 0 (0.0%) | 0.239 | Chemotherapy only | 3 (18.8%) | 4 (25.0%) | Radiotherapy only | 3 (18.8%) | 6 (37.5%) | None | 7 (43.8%) | 6 (37.5%) |
|
|